General information
Other names
| Where It's Done | Who Does It | How Long It Takes | Discomfort/Pain |
| Doctor's office, hospital, or commercial laboratory. | Doctor, nurse, or lab technician. | Less than 5 minutes for drawing blood. | Minor discomfort associated with drawing blood. |
| Results Ready When | Special Equipment | Risks/Complications | Average Cost |
| 1-3 days. | Supplies for drawing blood. | None. | $ |
Acute phase reactant.
Purpose- To check for severity of inflammatory disease and effectiveness of anti-inflammatory treatment.
- To help diagnose rheumatoid arthritis, which is characterized by high levels of CRP.
- Used for early detection of postoperative infection.
Blood test detects blood levels of C-reactive protein, or CRP, which appears in the blood during inflammatory diseases.
PreparationNone.
Test procedureBlood is drawn from a vein and analyzed for CRP. Several methods may be used for the analysis, including radioimmunoassay and agglutination.
After the testFollow procedure for drawing blood.
Factors affecting resultsPregnancy may increase CRP levels.
InterpretationCRP levels higher than 8 micrograms per milliliter may indicate presence of infection or inflammation.
Advantages- There's no risk.
- It may be more sensitive than the sedimentation rate in detecting early- and late-stage infection.
- It detects inflammation but not its cause (cannot be used to confirm a specific diagnosis).
- It's more complicated and expensive than sedimentation rate.
- If levels are elevated and arthritis is suspected, a rheumatoid factor test may be done. In other conditions, the test confirms the presence of systemic inflammation, and therapy may be started.
- If levels are normal, the test indicates lack of systemic inflammation, and no further tests are necessary.
The Patient's Guide to Medical Tests by Faculty Members at The Yale University of Medicine and G.S. Sharpe Communications, Inc. Copyright © 1997 by Yale University of Medicine and G.S. Sharpe Communications, Inc. Published by Houghton Mifflin Company. All rights reserved.